AUY News 8.17 07/24/2014 04:40:39 Yamana Gold (AUY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Yamana Gold (AUY) 8.17 $AUY

2 Mining Dividends You Can Buy Right Now, and 1 to Avoid
Sean Williams, The Motley Fool - Motley Fool - Sun Jul 20, 7:32AM CDT
All good things must eventually come to an end , but for metal enthusiasts it was an incredible 12-year ride! Lately, however, commodities prices of all forms have been languishing. Both gold and silver have had their moments where they've generated...

4 Stocks Under $10 Making Big Moves Higher
at The Street - Fri Jul 18, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Why Kinross Gold (KGC) Stock Is Sinking On Monday
at The Street - Mon Jul 14, 11:35AM CDT
Kinross Gold (KGC) stock is falling as the gold sector declines after August's gold futures dropped 2.2% to $1,307.50 per ounce.

Will Pan American Silver Reach Its Quarterly Goals?
Lior Cohen, The Motley Fool - Motley Fool - Mon Jul 14, 11:17AM CDT
Pan American Silver will release its second quarter earnings report next month. In anticipation of this release, let's review the main factors that could impact the company's stock.  Reaching production and costs goals In the first quarter, the...

Alamos Gold: Any Chance of Further Upside?
Vladimir Zernov, The Motley Fool - Motley Fool - Mon Jul 14, 8:31AM CDT
Shares of Alamos Gold rebounded from lows seen in early June, but they remain at depressed levels. Falling production mixed with difficulties in obtaining permits for key projects continue to weigh on the company's performance. However, not...

Will Yamana Gold Recover?
Lior Cohen, The Motley Fool - Motley Fool - Sat Jul 12, 8:41AM CDT
The recovery of gold seems to have glossed over shares of Yamana Gold , which haven't rallied this year. Conversely, other gold companies have done well in the stock market as their shares recovered in the past several months. Is the company's...

Agnico Eagle Hits a New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 11, 9:00AM CDT
Shares of Agnico Eagle Mines Limited (AEM) reached a new 52-week high of $41.79 on Jul 10, surpassing its previous high of $40.53.

Why Yamana Gold (AUY) Stock Is Up Today
at The Street - Thu Jul 10, 10:34AM CDT
Yamana Gold (AUY) rose Thursday as spot gold prices reached their highest levels since March.

SmarTrend Watching for Potential Pullback in Shares of Yamana Gold After 2.09% Gain
Comtex SmarTrend(R) - Wed Jul 09, 4:26PM CDT
Yamana Gold (NYSE:AUY) traded in a range yesterday that spanned from a low of $8.13 to a high of $8.34. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $8.27 on volume of 11.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of Yamana Gold to Potentially Pullback after Yesterday's 2.09% Rise
Comtex SmarTrend(R) - Wed Jul 09, 4:25PM CDT
Yamana Gold (NYSE:AUY) traded in a range yesterday that spanned from a low of $8.13 to a high of $8.34. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $8.27 on volume of 11.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Yamana Gold Announces Senior Management Appointment
Marketwire - Tue Jul 08, 3:15PM CDT
YAMANA GOLD INC. (TSX: YRI)(NYSE: AUY) ("Yamana" or "the Company" today announced Barry Murphy has joined the Company's senior management as Senior Vice President, Technical Services, effective September 3, 2014. In his new role, Mr. Murphy will be responsible for all project development and construction, and help develop Yamana's strategy for optimizations, expansions and corporate development.

3 Charts to Explain Goldcorp’s Recovery
Lior Cohen, The Motley Fool - Motley Fool - Mon Jul 07, 1:58PM CDT
Goldcorp has done well in the stock market in recent months, with its stock rising over 27% since the beginning of the year. The recovery of Goldcorp is partly due to the rise in the price of gold, but this isn't the only driving force. Here are...

Strategic Divestitures, Upcoming Quarterly Results, and Project Updates - Analyst Notes on Encana, Agnico Eagle, Yamana, Randgold and Statoil
PR Newswire - Thu Jul 03, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding Encana Corporation (NYSE: ECA), Agnico Eagle Mines Ltd (NYSE: AEM), Yamana Gold Inc. (NYSE: AUY), Randgold Resources Ltd (NASDAQ: GOLD) and Statoil ASA (NYSE: STO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4393-100free.

Yamana Provides Notice of Second Quarter 2014 Financial Results Release
Marketwire - Mon Jun 30, 8:35AM CDT
YAMANA GOLD INC. (TSX: YRI)(NYSE: AUY) ("Yamana" or "the Company" will release its second quarter 2014 results after market close on July 30, 2014 followed by a conference call and webcast on July 31, 2014 at 9:00 a.m. ET.

Is There More Upside Ahead for Agnico Eagle Mines?
Vladimir Zernov, The Motley Fool - Motley Fool - Sat Jun 28, 9:09AM CDT
Agnico Eagle Mines shares are among the best performers in the gold mining sector this year following the recent acquisition of Osisko Mining , which the company purchased together with Yamana Gold . However, even with the recent upside in gold...

Watch for Yamana Gold to Potentially Rebound After Falling 2.05% Yesterday
Comtex SmarTrend(R) - Thu Jun 26, 5:07PM CDT
Yamana Gold (NYSE:AUY) traded in a range yesterday that spanned from a low of $7.98 to a high of $8.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $8.17 on volume of 8.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 2.05%, Yamana Gold Offers Investors Better Value
Comtex SmarTrend(R) - Thu Jun 26, 5:06PM CDT
Yamana Gold (NYSE:AUY) traded in a range yesterday that spanned from a low of $7.98 to a high of $8.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $8.17 on volume of 8.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Jun 26, 12:45PM CDT
The S&P 500 's six-day winning streak finally came to a close earlier this week, but that hasn't stopped 49% of all stocks in The Motley Fool CAPS database from inching to within 10% or less of a new 52-week high. For skeptics like me, that's an...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading